Propanc Biopharma PPCB
NASDAQ PPCB
$0.49 -0.02 (-3.57%)
At close: Sep 30, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2018)

Updated

Propanc Biopharma (PPCB) recorded Long-Term Deferred Tax of $74,791 in fiscal Q4 2018 (quarter ended Jun 30, 2018), up 21.2% from $61,715 a year earlier.

Analysis

Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends

  • Across earlier fiscal years, Long-Term Deferred Tax came in at $61,715 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Propanc Biopharma 573,091.58 573,091.58 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 74,791.00
Jun 30, 2017 61,715.00
API Access

Propanc Biopharma Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PPCB&period=max&api_key=YOUR_API_KEY